Literature DB >> 15828690

An assessment of health status among medical research volunteers who served in the Project Whitecoat program at Fort Detrick, Maryland.

Phillip R Pittman1, Sarah L Norris, Kevin M Coonan, Kelly T McKee.   

Abstract

Between 1954 and 1973, more than 2000 men entering military service as conscientious objectors participated in Project Whitecoat as medical research volunteers for the Army's biological warfare defense program. An assessment of self-reported, current health status among 358 "exposed" individuals and 164 unexposed control subjects found no conclusive evidence that receipt of investigational agents was related to adverse health outcomes. No differences in current overall health, current exercise levels, self-reported symptoms, and self-reported medical conditions were seen between the study groups. Possible associations were seen between exposure to antibiotics or other biological agents and self-reported asthma (13.0% vs. 2.4%, relative risk [RR] = 6.00, 95% confidence interval [CI] = 1.03-34.90, p = 0.050), as well as between receipt of tularemia vaccine(s) and self-reported asthma (13.3% vs. 2.4%, RR = 6.15, 95% CI = 1.03-36.70, p = 0.049) and increased frequency/severity of headaches (35.6% vs. 18.3%, RR = 2.46, 95% CI = 0.99-6.15, p = 0.074). However, the size of the population under study was insufficient to assert with confidence that these statistical associations are real.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach; Fort Detrick; War and Human Rights Abuses

Mesh:

Substances:

Year:  2005        PMID: 15828690     DOI: 10.7205/milmed.170.3.183

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  5 in total

1.  Deliberate Microbial Infection Research Reveals Limitations to Current Safety Protections of Healthy Human Subjects.

Authors:  David L Evers; Carol B Fowler; Jeffrey T Mason; Rebecca K Mimnall
Journal:  Sci Eng Ethics       Date:  2014-08-24       Impact factor: 3.525

Review 2.  Antimicrobial therapies for Q fever.

Authors:  Gilbert J Kersh
Journal:  Expert Rev Anti Infect Ther       Date:  2013-09-27       Impact factor: 5.091

3.  Vaccination against Q fever for biodefense and public health indications.

Authors:  Sara Ruiz; Daniel N Wolfe
Journal:  Front Microbiol       Date:  2014-12-16       Impact factor: 5.640

4.  Retrospective Analysis of Pneumonic Tularemia in Operation Whitecoat Human Subjects: Disease Progression and Tetracycline Efficacy.

Authors:  Mark S Williams; Marianne R Baker; Tina Guina; Judith A Hewitt; Lynda Lanning; Heather Hill; Jeanine M May; Beverly Fogtman; Phillip R Pittman
Journal:  Front Med (Lausanne)       Date:  2019-10-22

5.  Novel Transcriptional and Translational Biomarkers of Tularemia Vaccine Efficacy in a Mouse Inhalation Model: Proof of Concept.

Authors:  Qing Yan Liu; Sonia Leclerc; Youlian Pan; Ziying Liu; Felicity Stark; Joseph Wayne Conlan
Journal:  Microorganisms       Date:  2021-12-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.